Annual ROE
536.37%
+102.37%+23.59%
December 31, 2023
Summary
- As of March 12, 2025, PBLA annual return on equity is 536.37%, with the most recent change of +102.37% (+23.59%) on December 31, 2023.
- During the last 3 years, PBLA annual ROE has risen by +592.81% (+1050.34%).
- PBLA annual ROE is now at all-time high.
Performance
PBLA ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
304.71%
-240.74%-44.14%
September 30, 2024
Summary
- As of March 12, 2025, PBLA quarterly return on equity is 304.71%, with the most recent change of -240.74% (-44.14%) on September 30, 2024.
- Over the past year, PBLA quarterly ROE has stayed the same.
- PBLA quarterly ROE is now -90.00% below its all-time high of 3048.40%, reached on March 31, 2019.
Performance
PBLA Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
PBLA ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +23.6% | 0.0% |
| 3 y3 years | +1050.3% | -61.0% |
| 5 y5 years | +124.3% | -61.0% |
PBLA ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +640.4% | -89.7% | +100.4% |
| 5 y | 5-year | at high | +219.8% | -89.7% | +100.4% |
| alltime | all time | at high | +124.3% | -90.0% | +100.4% |
Panbela Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 304.71%(-44.1%) |
| Jun 2024 | - | 545.45%(-72.1%) |
| Mar 2024 | - | 1955.03%(-102.8%) |
| Dec 2023 | 536.37%(+23.6%) | -70.14 K%(-2482.9%) |
| Sep 2023 | - | 2943.60%(+229.5%) |
| Jun 2023 | - | 893.47%(+14.4%) |
| Mar 2023 | - | 781.06%(-18.5%) |
| Dec 2022 | 434.00%(-537.3%) | 958.05%(-126.1%) |
| Sep 2022 | - | -3670.95%(+641.1%) |
| Jun 2022 | - | -495.33%(+288.3%) |
| Mar 2022 | - | -127.57%(+17.1%) |
| Dec 2021 | -99.25%(+75.9%) | -108.96%(+29.2%) |
| Sep 2021 | - | -84.36%(-5.1%) |
| Jun 2021 | - | -88.86%(+15.5%) |
| Mar 2021 | - | -76.92%(-18.0%) |
| Dec 2020 | -56.44%(-87.4%) | -93.85%(-36.0%) |
| Sep 2020 | - | -146.69%(-51.0%) |
| Jun 2020 | - | -299.44%(-48.9%) |
| Mar 2020 | - | -585.89%(-27.5%) |
| Dec 2019 | -447.65%(-79.7%) | -808.08%(-33.9%) |
| Sep 2019 | - | -1222.54%(-154.2%) |
| Jun 2019 | - | 2254.14%(-26.1%) |
| Mar 2019 | - | 3048.40%(+220.7%) |
| Dec 2018 | -2203.36% | 950.56%(+109.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | 454.84%(+19.4%) |
| Jun 2018 | - | 381.00%(+31.9%) |
| Mar 2018 | - | 288.96%(-55.4%) |
| Dec 2017 | 281.21%(+155.4%) | 647.43%(+14.0%) |
| Sep 2017 | - | 567.76%(+20.7%) |
| Jun 2017 | - | 470.29%(+24.5%) |
| Mar 2017 | - | 377.79%(+163.7%) |
| Dec 2016 | 110.12%(-40.1%) | 143.28%(+22.4%) |
| Sep 2016 | - | 117.08%(-4.7%) |
| Jun 2016 | - | 122.91%(-26.2%) |
| Mar 2016 | - | 166.61%(-54.9%) |
| Dec 2015 | 183.77%(-31.5%) | 369.59%(-29.2%) |
| Sep 2015 | - | 521.75%(-44.4%) |
| Jun 2015 | - | 938.84%(+22.0%) |
| Mar 2015 | - | 769.37%(+86.7%) |
| Dec 2014 | 268.31%(+74.5%) | 412.09%(-19.4%) |
| Sep 2014 | - | 510.98%(+311.7%) |
| Jun 2014 | - | 124.12%(-22.2%) |
| Mar 2014 | - | 159.56%(-14.5%) |
| Dec 2013 | 153.73%(-125.4%) | 186.61%(+128.2%) |
| Sep 2013 | - | 81.76%(-197.0%) |
| Jun 2013 | - | -84.28%(-73.6%) |
| Mar 2013 | - | -318.83%(-47.4%) |
| Dec 2012 | -606.37%(-1875.6%) | -606.37% |
| Dec 2011 | 34.15% | - |
FAQ
- What is Panbela Therapeutics annual return on equity?
- What is the all time high annual ROE for Panbela Therapeutics?
- What is Panbela Therapeutics annual ROE year-on-year change?
- What is Panbela Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Panbela Therapeutics?
- What is Panbela Therapeutics quarterly ROE year-on-year change?
What is Panbela Therapeutics annual return on equity?
The current annual ROE of PBLA is 536.37%
What is the all time high annual ROE for Panbela Therapeutics?
Panbela Therapeutics all-time high annual return on equity is 536.37%
What is Panbela Therapeutics annual ROE year-on-year change?
Over the past year, PBLA annual return on equity has changed by +102.37% (+23.59%)
What is Panbela Therapeutics quarterly return on equity?
The current quarterly ROE of PBLA is 304.71%
What is the all time high quarterly ROE for Panbela Therapeutics?
Panbela Therapeutics all-time high quarterly return on equity is 3048.40%
What is Panbela Therapeutics quarterly ROE year-on-year change?
Over the past year, PBLA quarterly return on equity has changed by 0.00% (0.00%)